Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16920
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRoberts, Blaine R-
dc.contributor.authorLind, Monica-
dc.contributor.authorWagen, Aaron Z-
dc.contributor.authorRembach, Alan-
dc.contributor.authorFrugier, Tony-
dc.contributor.authorLi, Qiao-Xin-
dc.contributor.authorRyan, Timothy M-
dc.contributor.authorMcLean, Catriona A-
dc.contributor.authorDoecke, James D-
dc.contributor.authorRowe, Christopher C-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorMasters, Colin L-
dc.date.accessioned2017-11-01T23:34:06Z-
dc.date.available2017-11-01T23:34:06Z-
dc.date.issued2017-05-01-
dc.identifier.citationBrain 2017; 140(5): 1486-1498en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16920-
dc.description.abstractWe fractionated frontal cortical grey matter from human Alzheimer's disease and control subjects into four biochemically defined pools that represent four distinct compartments: soluble/cytosolic, peripheral membrane/vesicular cargo, integral lipid/membranous pools and aggregated/insoluble debris. Most of the readily extractable amyloid-β remains associated with a lipid/membranous compartment. There is an exchange of amyloid-β between the biochemical pools that was lost for the amyloid-β42 species in Alzheimer's disease, consistent with the peptide being irreversibly trapped in extracellular deposits. The quantitative amyloid-β data, combined with magnetic resonance imaging volumetric analysis of the amount of cortical grey matter in brain, allowed us to estimate the total mass of amyloid-β in Alzheimer's disease (6.5 mg) and control (1.7 mg) brains. The threshold positron emission tomography standard uptake value ratio of 1.4 equates to 5.0 μg amyloid-β/g of grey matter and the mean Alzheimer's disease dementia standard uptake value ratio level of 2.3 equates to 11.20 μg amyloid-β/g of grey matter. It takes 19 years to accumulate amyloid from the threshold positron emission tomography standard uptake value ratio to the mean value observed for Alzheimer's disease dementia. This accumulation time window combined with the difference of 4.8 mg of amyloid-β between Alzheimer's disease and control brain allows for a first approximation of amyloid-β accumulation of 28 ng/h. This equates to an estimated 2-5% of the total amyloid-β production being deposited as insoluble plaques. Understanding these rates of amyloid-β accumulation allows for a more quantitative approach in targeting the failure of amyloid-β clearance in sporadic Alzheimer's disease.en
dc.subjectAlzheimer’s diseaseen
dc.subjectamyloid imagingen
dc.subjectamyloid-βen
dc.subjectbiomarkersen
dc.titleBiochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PETen
dc.typeJournal Articleen
dc.identifier.journaltitleBrainen
dc.identifier.affiliationThe Florey Institute, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Pharmacology and Therapeutics, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Anatomical Pathology, Alfred Hospital, Prahran, Victoria, Australiaen
dc.identifier.affiliationCSIRO Health and Biosecurity/Australian e-Health Research Centre and Cooperative Research Centre of Mental Health, Brisbane, QLD, Australiaen
dc.identifier.affiliationDepartment of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/28383676en
dc.identifier.doi10.1093/brain/awx057en
dc.type.contentTexten
dc.identifier.orcid0000-0003-3910-2453en
dc.type.austinJournal Articleen_US
local.name.researcherMasters, Colin L
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.